Skip to main content
SpringerLink
Log in

Large cell carcinoma of the lung – a vanishing entity?

  • Short review
  • Published:
memo - Magazine of European Medical Oncology Aims and scope Submit manuscript

Summary

There are four major types of lung carcinomas, small cell neuroendocrine carcinoma, squamous cell carcinoma, adenocarcinoma and large cell carcinomas (LC) [1]. Since the mid nineties the incidence of adenocarcinomas has increased; whereas squamous and small cell carcinomas have decreased dramatically [2, 3]. LC, however, remained constant at about 10–12% of all lung carcinomas. However, LC should not be mixed with large cell carcinoma variants including large cell neuroendocrine carcinoma, clear cell carcinoma, rhabdoid large cell carcinoma, basaloid, and lymphoepithelioma-like carcinoma, respectively. Whereas a lot of published data do exist for the LC variants, only few studies have investigated LC itself. Due to an increased use of differentiation markers in the diagnostic practice LC seems to decrease in frequency, and might even vanish. This review will try to explain the problems of LC diagnosis, the false use of this diagnosis, and reasons why LC is becoming a rare entity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Travis WD, Brambilla E, Müller-Hermelink HK, Harris CC. Pathology and Genetics of tumours of the lung, pleura, thymus and heart, Vol. 10. IARC WHO Classification of Tumours, IARC Press, Lyon, France, 2004

    Google Scholar 

  • Wynder EL, Muscat JE. The changing epidemiology of smoking and lung cancer histology, Environ Health Perspect, 103(Suppl. 8): 143–148, 1995

    Article  PubMed  Google Scholar 

  • Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW Jr. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst, 89: 1580–1586, 1997

    Article  PubMed  CAS  Google Scholar 

  • Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB, Nieman L, Chrousos G, Pass H, Doppman J. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. An ultrastructural, immunohistochemical, and flow cytometric study of 35 cases. Am J Surg Pathol, 15: 529–553, 1991

    Article  PubMed  CAS  Google Scholar 

  • Forgacs E, Zochbauer-Muller S, Olah E, Minna JD. Molecular genetic abnormalities in the pathogenesis of human lung cancer. Pathol Oncol Res, 7: 6–13, 2001

    Article  PubMed  CAS  Google Scholar 

  • Osada H, Takahashi T. Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer. Oncogene 21: 7421–7434, 2002

    Article  PubMed  CAS  Google Scholar 

  • Borczuk AC, Gorenstein L, Walter KL, Assaad AA, Wang L, Powell CA. Non-small-cell lung cancer molecular signatures recapitulate lung developmental pathways. Am J Pathol, 163: 1949–1960, 2003

    Article  PubMed  CAS  Google Scholar 

  • Sy SM, Wong N, Lee TW, Tse G, Mok TS, Fan B, Pang E, Johnson PJ, Yim A. Distinct patterns of genetic alterations in adenocarcinoma and squamous cell carcinoma of the lung. Eur J Cancer, 40: 1082–1094, 2004

    Article  PubMed  CAS  Google Scholar 

  • Kang JU, Koo SH, Kwon KC, Park JW, Kim JM. Identification of novel candidate target genes, including EPHB3, MASP1 and SST at 3q26.2–q29 in squamous cell carcinoma of the lung. BMC Cancer, 9: 237, 2009

    Article  PubMed  Google Scholar 

  • Mascaux C, Laes JF, Anthoine G, Haller A, Ninane V, Burny A, Sculier JP. Evolution of microRNA expression during human bronchial squamous carcinogenesis, Eur Respir J, 33: 352–359, 2009

    Article  PubMed  CAS  Google Scholar 

  • Bjorkqvist AM, Tammilehto L, Nordling S, Nurminen M, Anttila S, Mattson K, Knuutila S. Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung Br J Cancer, 77: 260–269, 1998

    Article  PubMed  CAS  Google Scholar 

  • Franklin WA, Veve R, Hirsch FR, Helfrich BA, Bunn PA Jr. Epidermal growth factor receptor family in lung cancer and premalignancy, Semin Oncol, 29: 3–14, 2002

    Article  PubMed  CAS  Google Scholar 

  • Dziadziuszko R, Merrick DT, Witta SE, Mendoza AD, Szostakiewicz B, Szymanowska A, Rzyman W, Dziadziuszko K, Jassem J, Bunn PA Jr, Varella-Garcia M, Hirsch FR. Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression. J Clin Oncol, 28: 2174–2180, 2010

    Article  PubMed  Google Scholar 

  • Ludovini V, Bellezza G, Pistola L, Bianconi F, Di Carlo L, Sidoni A, Semeraro A, Del Sordo R, Tofanetti FR, Mameli MG, Daddi G, Cavaliere A, Tonato M, Crino L. High coexpression of both insulin-like growth factor receptor-1 (IGFR-1) and epidermal growth factor receptor (EGFR) is associated with shorter disease-free survival in resected non-small-cell lung cancer patients. Ann Oncol, 20: 842–849, 2009

    Article  PubMed  CAS  Google Scholar 

  • Marchetti A, Martella C, Felicioni L, Barassi F, Salvatore S, Chella A, Camplese PP, Iarussi T, Mucilli F, Mezzetti A, Cuccurullo F, Sacco R, Buttitta F. EGFR mutations in non-small-cell lung cancer: analysis of a large series of cases and development of a rapid and sensitive method for diagnostic screening with potential implications on pharmacologic treatment. J Clin Oncol, 23: 857–865, 2005

    Article  PubMed  CAS  Google Scholar 

  • Pardo J, Martinez-Penuela AM, Sola JJ, Panizo A, Gurpide A, Martinez-Penuela JM, Lozano MD. Large cell carcinoma of the lung: an endangered species? Appl Immunohistochem Mol Morphol, 17: 383–392, 2009

    Article  PubMed  Google Scholar 

  • Hanagiri T, Oka S, Takenaka S, Baba T, Yasuda M, Ono K, So T, Uramoto H, Takenoyama M, Yasumoto K. Results of surgical resection for patients with large cell carcinoma of the lung. Int J Surg, 8: 391–394, 2010

    Article  PubMed  Google Scholar 

  • Conde E, Angulo B, Redondo P, Toldos O, Garcia-Garcia E, Suarez-Gauthier A, Rubio-Viqueira B, Marron C, Garcia-Lujan R, Sanchez-Cespedes M, Lopez-Encuentra A, Paz-Ares L, Lopez-Rios F. The use of P63 immunohistochemistry for the identification of squamous cell carcinoma of the lung. PLoS One, 5: e12209, 2010

    Article  PubMed  Google Scholar 

  • Monica V, Ceppi P, Righi L, Tavaglione V, Volante M, Pelosi G, Scagliotti GV, Papotti M. Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung, Mod Pathol, 22: 709–717, 2009

    Article  PubMed  CAS  Google Scholar 

  • Ring BZ, Seitz RS, Beck RA, Shasteen WJ, Soltermann A, Arbogast S, Robert F, Schreeder MT, Ross DT. A novel five-antibody immunohistochemical test for subclassification of lung carcinoma, Mod Pathol, 22: 1032–1043, 2009

    Article  PubMed  CAS  Google Scholar 

  • Hammar SP, Bolen JW, Bockus D, Remington F, Friedman S: Ultrastructural and immunohistochemical features of common lung tumors: an overview. Ultrastruct Pathol, 9: 283–318, 1985

    Article  PubMed  CAS  Google Scholar 

  • Moll R, Cowin P, Kapprell HP, Franke WW. Desmosomal proteins: new markers for identification and classification of tumors, Lab Invest, 54: 4–25, 1986

    PubMed  CAS  Google Scholar 

  • Brambilla E, Travis WD, Colby TV, Corrin B, Shimosato Y. The new world health organization classification of lung tumours. Eur Respir J, 18: 1059–1068, 2001

    Article  PubMed  CAS  Google Scholar 

  • Au NH, Gown AM, Cheang M, Huntsman D, Yorida E, Elliott WM, Flint J, English J, Gilks CB. Grimes HL: P63 expression in lung carcinoma: a tissue microarray study of 408 cases, Appl Immunohistochem Mol Morphol, 12: 240–247, 2004

    PubMed  CAS  Google Scholar 

  • Petersen S, Heckert C, Rudolf J, Schluns K, Tchernitsa OI, Schafer R, Dietel M, Petersen I. Gene expression profiling of advanced lung cancer. Int J Cancer, 86: 512–517, 2000

    Article  PubMed  CAS  Google Scholar 

  • Bhattacharjee A, Richards WG, Staunton J, Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, Loda M, Weber G, Mark EJ, Lander ES, Wong W, Johnson BE, Golub TR, Sugarbaker DJ, Meyerson M. Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses, Proc Natl Acad Sci USA, 98: 13790–13795, 2001

    Article  PubMed  CAS  Google Scholar 

  • Heighway J, Knapp T, Boyce L, Brennand S, Field JK, Betticher DC, Ratschiller D, Gugger M, Donovan M, Lasek A, Rickert P. Expression profiling of primary non-small cell lung cancer for target identification. Oncogene, 21: 7749–7763, 2002

    Article  PubMed  CAS  Google Scholar 

  • Virtanen C, Ishikawa Y, Honjoh D, Kimura M, Shimane M, Miyoshi T, Nomura H, Jones MH. Integrated classification of lung tumors and cell lines by expression profiling. Proc Natl Acad Sci USA, 99: 12357–12362, 2002

    Article  PubMed  CAS  Google Scholar 

  • Ikehara M, Oshita F, Sekiyama A, Hamanaka N, Saito H, Yamada K, Noda K, Kameda Y, Miyagi Y. Genome-wide cDNA microarray screening to correlate gene expression profile with survival in patients with advanced lung cancer. Oncol Rep, 11: 1041–1044, 2004

    PubMed  CAS  Google Scholar 

  • Chao YC, Pan SH, Yang SC, Yu SL, Che TF, Lin CW, Tsai MS, Chang GC, Wu CH, Wu YY, Lee YC, Hong TM, Yang PC. Claudin-1 is a metastasis suppressor and correlates with clinical outcome in lung adenocarcinoma. Am J Respir Crit Care Med, 179: 123–133, 2009

    Article  PubMed  CAS  Google Scholar 

  • Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, Gerald WL, Eschrich S, Jurisica I, Giordano TJ, Misek DE, Chang AC, Zhu CQ, Strumpf D, Hanash S, Shepherd FA, Ding K, Seymour L, Naoki K, Pennell N, Weir B, Verhaak R, Ladd-Acosta C, Golub T, Gruidl M, Sharma A, Szoke J, Zakowski M, Rusch V, Kris M, Viale A, Motoi N, Travis W, Conley B, Seshan VE, Meyerson M, Kuick R, Dobbin KK, Lively T, Jacobson JW, Beer DG. Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med, 14: 822–827, 2008

    Article  PubMed  CAS  Google Scholar 

  • Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, Yuan A, Cheng CL, Wang CH, Terng HJ, Kao SF, Chan WK, Li HN, Liu CC, Singh S, Chen WJ, Chen JJ, Yang PC. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med, 356: 11–20, 2007

    Article  PubMed  CAS  Google Scholar 

  • Rossi G, Pelosi G, Graziano P, Barbareschi M, Papotti M. A reevaluation of the clinical significance of histological subtyping of non-small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments. Int J Surg Pathol, 17: 206–218, 2009

    Article  PubMed  Google Scholar 

  • Girard N, Deshpande C, Lau C, Finley D, Rusch V, Pao W, Travis WD. Comprehensive histologic assessment helps to differentiate multiple lung primary nonsmall cell carcinomas from metastases. Am J Surg Pathol, 33: 1752–1764, 2009

    Article  PubMed  Google Scholar 

  • Loo PS, Thomas SC, Nicolson MC, Fyfe MN, Kerr KM. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. J Thorac Oncol, 5: 442–447, 2010

    Article  PubMed  Google Scholar 

  • Ou SH, Zell JA. Carcinoma NOS is a common histologic diagnosis and is increasing in proportion among non-small cell lung cancer histologies. J Thorac Oncol, 4: 1202–1211, 2009

    Article  PubMed  Google Scholar 

  • Rivera MP, Mehta AC. Initial diagnosis of lung cancer: ACCP evidence-based clinical practice guidelines, (2nd edn). Chest, 132: 131S–148S, 2007

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Unit Molecular Lung and Pleura Pathology, Institute of Pathology, Medical University of Graz, Graz, Austria

    H. H. Popper

Authors
  1. H. H. Popper
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to H. H. Popper.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Popper, H. Large cell carcinoma of the lung – a vanishing entity?. memo 4, 4–9 (2011). https://doi.org/10.1007/s12254-011-0245-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12254-011-0245-8

Keywords

Search

Navigation